DYNT Stock Overview
A medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Dynatronics Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.12 |
| 52 Week High | US$0.73 |
| 52 Week Low | US$0.092 |
| Beta | 0.17 |
| 11 Month Change | -7.62% |
| 3 Month Change | -27.21% |
| 1 Year Change | -79.98% |
| 33 Year Change | -97.71% |
| 5 Year Change | -96.54% |
| Change since IPO | -99.27% |
Recent News & Updates
Recent updates
Dynatronics Corporation's (NASDAQ:DYNT) Intrinsic Value Is Potentially 25% Below Its Share Price
Oct 12
The Consensus EPS Estimates For Dynatronics Corporation (NASDAQ:DYNT) Just Fell Dramatically
May 16Dynatronics GAAP EPS of -$0.10 misses by $0.02, revenue of $11.19M misses by $0.03M
Sep 22Dynatronics makes key appointments; names new CFO
Jul 06There Are Some Holes In Dynatronics' (NASDAQ:DYNT) Solid Earnings Release
Sep 30Health Check: How Prudently Does Dynatronics (NASDAQ:DYNT) Use Debt?
Jul 24We Think Dynatronics (NASDAQ:DYNT) Has A Fair Chunk Of Debt
Apr 09When Will Dynatronics Corporation (NASDAQ:DYNT) Become Profitable?
Feb 16
Dynatronics (NASDAQ:DYNT) Is Carrying A Fair Bit Of Debt
Dec 25Dynatronics appoints Norman Roegner III as CFO
Nov 09Shareholder Returns
| DYNT | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -7.7% | 0.8% | 0.5% |
| 1Y | -80.0% | 20.5% | 30.7% |
Return vs Industry: DYNT underperformed the US Medical Equipment industry which returned 22.5% over the past year.
Return vs Market: DYNT underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| DYNT volatility | |
|---|---|
| DYNT Average Weekly Movement | 29.0% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DYNT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: DYNT's weekly volatility has increased from 21% to 29% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 112 | Brian Baker | www.dynatronics.com |
Dynatronics Corporation, a medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally. It offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment.
Dynatronics Corporation Fundamentals Summary
| DYNT fundamental statistics | |
|---|---|
| Market cap | US$871.39k |
| Earnings (TTM) | -US$3.44m |
| Revenue (TTM) | US$30.78m |
0.0x
P/S Ratio-0.3x
P/E RatioIs DYNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DYNT income statement (TTM) | |
|---|---|
| Revenue | US$30.78m |
| Cost of Revenue | US$23.47m |
| Gross Profit | US$7.31m |
| Other Expenses | US$10.74m |
| Earnings | -US$3.44m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.47 |
| Gross Margin | 23.75% |
| Net Profit Margin | -11.16% |
| Debt/Equity Ratio | 13.7% |
How did DYNT perform over the long term?
See historical performance and comparison